Carolyn Tang
Fortune : 5 M $ au 31/05/2026
Fortune : 5 M $ au 31/05/2026
Carolyn Tang is currently General Counsel at Arcus Biosciences, Inc. since 2019.
Formerly, Ms. Tang was Director-Securities and Transactions at MediVation, Inc. from 2015 to 2017.
Ms. Tang completed undergraduate studies at the University of California, Berkeley in 2001 and graduate studies at The Santa Clara University School of Law in 2012.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 184 607 ( 0,15% ) | 5 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Conseiller Juridique Général | 01/07/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
MediVation, Inc. /MA/
MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services Provides fully automated Web-based communications systems to educate and communicate with patients securely on-line | Corporate Officer/Principal | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
MediVation, Inc. /MA/
MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services Provides fully automated Web-based communications systems to educate and communicate with patients securely on-line | Technology Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Santa Clara University School of Law
The Santa Clara University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national